tiprankstipranks
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD
US Market
ACAD
ACADIA Pharmaceuticals
RESEARCH TOOLSreports

ACADIA Pharmaceuticals (ACAD) Financial Statements

Compare
2,433 Followers

ACADIA Pharmaceuticals Financial Overview

ACADIA Pharmaceuticals's market cap is currently $3.54B. The company's EPS TTM is $1.6; its P/E ratio is 11.57; ACADIA Pharmaceuticals is scheduled to report earnings on February 25, 2026, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 1.07B$ 957.80M$ 726.44M$ 517.24M$ 484.14M
Gross Profit$ 982.51M$ 875.96M$ 680.71M$ 507.07M$ 465.00M
Operating Income$ 104.81M$ 230.79M$ -73.38M$ -223.60M$ -170.44M
EBITDA$ 138.90M$ 100.16M$ -67.83M$ -221.57M$ -167.09M
Net Income$ 391.00M$ 226.45M$ -61.29M$ -215.97M$ -167.87M
Balance Sheet
Cash & Short-Term Investments$ 819.69M$ 755.99M$ 438.87M$ 416.82M$ 520.71M
Total Assets$ 1.56B$ 1.19B$ 748.96M$ 587.81M$ 700.12M
Total Debt$ 52.19M$ 51.99M$ 57.20M$ 62.00M$ 64.43M
Net Debt$ -125.51M$ -267.59M$ -131.45M$ -52.85M$ -83.00M
Total Liabilities$ 336.81M$ 454.96M$ 317.20M$ 187.40M$ 159.23M
Stockholders' Equity$ 1.23B$ 732.79M$ 431.75M$ 400.41M$ 540.89M
Cash Flow
Free Cash Flow$ 105.15M$ 157.20M$ -23.35M$ -114.03M$ -126.78M
Operating Cash Flow$ 109.84M$ 157.72M$ 16.70M$ -114.03M$ -125.66M
Investing Cash Flow$ -302.56M$ -30.54M$ 32.00M$ 73.24M$ -71.10M
Financing Cash Flow$ 49.88M$ 6.84M$ 25.13M$ 8.20M$ 18.16M
Currency in USD

ACADIA Pharmaceuticals Earnings and Revenue History

Income Statement >

ACADIA Pharmaceuticals Debt to Assets

Balance Sheet >

ACADIA Pharmaceuticals Cash Flow

Cash Flow >

ACADIA Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >